What is the current market price of Ivosidenib per box?

Ivosidenib (Ivosidenib) has been officially launched in China and has become a new option for treating patients with certain types of tumors. Although it can be purchased through formal channels in China, the price of medicines is relatively high because they are not yet included in medical insurance. It is understood that the domestic price of Avonib is about 30,000 to 40,000 yuan per box. The specific price will vary depending on the region and hospital. Patients need to consult the local hospital pharmacy for confirmation when purchasing.

In comparison, the price of Avonib in foreign markets is relatively more affordable. In particular, the price of the generic version produced in Laos is only about 3,000 yuan, which is far lower than the price of the domestic original drug. Although the price gap is large, the main pharmaceutical ingredients of this type of generic drugs are basically the same as those of the original drugs, which can provide patients with affordable medication options, especially suitable for patients with limited budget or insufficient medical insurance coverage.

It should be noted that although generic drugs have an advantage in price, patients should ensure that the source of drugs is regular when choosing, and avoid buying fake and shoddy products. At the same time, it is recommended to use medications rationally under the guidance of a doctor to ensure medication safety and therapeutic effect. Whether you choose domestic original drugs or overseas generic drugs, the advice of professional medical institutions is very important.

Overall, there are obvious differences in the market price of ivonib. The price of domestic original drugs is higher, while the price of overseas generic drugs, especially in Laos, is lower. Patients can choose the appropriate medication channel based on their own economic situation and treatment needs, combined with the advice of doctors. If Avonib is included in medical insurance in the future, the price is expected to drop further, bringing good news to more patients.

Reference link:https://www.tibsovo.com/